Arlene Flores, in Bayamon, SD - General Practice

Arlene Flores, is a General Practice physician based in Bayamon, South Dakota. Arlene Flores is licensed to practice in Puerto Rico (license number 15630) and her current practice location is Camino Aviles Res Carr 830, Km5.2 Cerro Gordo, Bayamon, South Dakota. She can be reached at her office (for appointments etc.) via phone at (787) 767-8758.

NPI number for Arlene Flores is 1548477565 and her current mailing address is Rr 4 Box 820, Cerro Gordo, Bayamon, Puerto Rico. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1548477565.

Contact Information

	Arlene Flores,
	Camino Aviles Res Carr 830, Km5.2 Cerro Gordo, Bayamon, SD 00956-9606
	(787) 767-8758
	Not Available

Physician's Profile

Full Name	Arlene Flores
Gender	Female
Speciality	General Practice
Location	Camino Aviles Res Carr 830, Bayamon, South Dakota
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1548477565
Provider Enumeration Date: 05/17/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Arlene Flores such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1548477565	NPI	-	NPPES
15630	Other	PR	LICENSE

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	15630 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Arlene Flores is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Arlene Flores, Rr 4 Box 820, Cerro Gordo, Bayamon, PR 00956-9606 Ph: () -	Arlene Flores, Camino Aviles Res Carr 830, Km5.2 Cerro Gordo, Bayamon, SD 00956-9606 Ph: (787) 767-8758

News Archive

Christiana Care Health System opens first Epilepsy Monitoring Unit in Delaware

To increase access to advanced neurological care, Christiana Care Health System has opened the first Epilepsy Monitoring Unit in the First State.

LABEC Pharma meets European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test

Interleukin Genetics, Inc. and LABEC Pharma, S.L. announced today that LABEC Pharma has met European regulatory guidelines to sell Interleukin Genetics' Heart Health genetic test. The test, which helps to identify individuals at elevated risk for early heart attack, will be marketed to physicians in Spain and Portugal by LABEC Pharma under the product name Cardio Health™.

Wall Street Journal examines potential implications of allegedly fake U.S. vaccination campaign in Pakistan

The Wall Street Journal reports on how "a reportedly fake vaccination campaign conducted by the U.S. to help hunt down Osama bin Laden has caused a backlash against international health workers in some parts of Pakistan and has impeded efforts to wipe out polio in the country," one of only four worldwide where polio remains endemic.

DHA improves memory function in older adults with mild cognitive impairments

A study published in the November edition of Alzheimer's & Dementia: The Journal of the Alzheimer's Association suggests that taking docosahexaenoic acid (DHA) may improve memory and learning in older adults with mild cognitive impairments. This is promising news for many aging Americans who are searching for options to maintain memory and support overall cognitive health.

Patheon releases the first commercial shipments of SUMAVEL DosePro to Zogenix

Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has successfully released the first commercial shipments of SUMAVEL DosePro (sumatriptan injection) to Zogenix in anticipation of the planned U.S. commercial product launch scheduled in January 2010.

Arlene Flores, - General Practice in Bayamon, SD